Provided by Tiger Fintech (Singapore) Pte. Ltd.

Mainz Biomed B.V.

4.37
-0.3650-7.72%
Post-market: 4.35-0.0150-0.34%19:57 EDT
Volume:107.70K
Turnover:480.34K
Market Cap:14.71M
PE:-0.10
High:4.84
Open:4.80
Low:4.20
Close:4.73
Loading ...
Dec 11, 2024

[Amend]Public Prospectus

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
Dec 11, 2024

Correspondence

Form CORRESP - Correspondence
Dec 11, 2024

Correspondence

Form CORRESP - Correspondence
Dec 09, 2024

[Amend]Public Prospectus

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
Dec 09, 2024

[Amend]Public Prospectus

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
Nov 05, 2024

Public Prospectus

Form F-1 - Registration statement for certain foreign private issuers
Oct 08, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Apr 09, 2024

Annual Report

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Feb 13, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jul 11, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Apr 07, 2023

Annual Report

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Mar 01, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 05, 2023

Correspondence

CORRESP [Cover] - Correspondence
May 16, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
May 16, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
May 03, 2022

Annual Report

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]